Browse > Article
http://dx.doi.org/10.3340/jkns.2011.50.4.281

Radiological Apoplexy and Its Correlation with Acute Clinical Presentation, Angiogenesis and Tumor Microvascular Density in Pituitary Adenomas  

Lee, Jung-Sup (Department of Neurosurgery, College of Medicine, Chung-Ang University)
Park, Yong-Sook (Department of Neurosurgery, College of Medicine, Chung-Ang University)
Kwon, Jeong-Taik (Department of Neurosurgery, College of Medicine, Chung-Ang University)
Nam, Taek-Kyun (Department of Neurosurgery, College of Medicine, Chung-Ang University)
Lee, Tae-Jin (Department of Pathology, College of Medicine, Chung-Ang University)
Kim, Jae-Kyun (Department of Neurosurgery, College of Medicine, Chung-Ang University)
Publication Information
Journal of Korean Neurosurgical Society / v.50, no.4, 2011 , pp. 281-287 More about this Journal
Abstract
Objective : Pituitary apoplexy is life-threatening clinical syndrome caused by the rapid enlargement of a pituitary tumor due to hemorrhage and/or infarction. The pathogenesis of pituitary apoplexy is not completely understood. We analyzed the magnetic resonance imaging (MRI) of pituitary tumors and subsequently correlated the radiological findings with the clinical presentation. Additionally, immunohistochemistry was also performed to determine whether certain biomarkers are related to radiological apoplexy. Methods : Thirty-four cases of pituitary adenoma were enrolled for retrospective analysis. In this study, the radiological apoplexy was defined as cases where hemorrhage, infarction or cysts were identified on MRI. Acute clinical presentation was defined as the presence of any of the following symptoms: severe sudden onset headache, decreased visual acuity and/or visual field deficit, and acute mental status changes. Angiogenesis was quantified by immunohistochemical expression of fetal liver kinase 1 (Flk-1), neuropilin (NRP) and vascular endothelial growth factor (VEGF) expression, while microvascular density (MVD) was assessed using Endoglin and CD31. Results : Clinically, fourteen patients presented with acute symptoms and 20 for mild or none clinical symptoms. Radiologically, fifteen patients met the criteria for radiological apoplexy. Of the fifteen patients with radiologic apoplexy, 9 patients presented acute symptoms whereas of the 19 patient without radiologic apoplexy, 5 patients presented acute symptoms. Of the five biomarkers tracked, only VEGF was found to be positively correlated with both radiological and nonradiological apoplexy. Conclusion : While pituitary apoplexy is currently defined in cases where clinical symptoms can be histologically confirmed, we contend that cases of radiologically identified pituitary hemorrhages that present with mild or no symptoms should be designated subacute or subclinical apoplexy. VEGF is believed to have a positive correlation with pituitary hemorrhage. Considering the high rate of symptomatic or asymptomatic pituitary tumor hemorrhage, additional studies are needed to detect predictors of the pituitary hemorrhage.
Keywords
Pituitary adenoma; Pituitary apoplexy; Pituitary hemorrhage; Angiogenesis; Microvascular density; VEGF;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
  • Reference
1 Verrees M, Arafah BM, Selman WR : Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 16 : E6, 2004
2 Wakai S, Fukushima T, Teramoto A, Sano K : Pituitary apoplexy : its incidence and clinical significance. J Neurosurg 55 : 187-193, 1981   DOI
3 Wakai S, Yamakawa K, Manaka S, Takakura K : Spontaneous intracranial hemorrhage caused by brain tumor : its incidence and clinical significance. Neurosurgery 10 : 437-444, 1982   DOI
4 Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J : Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143 : 401-409, 1993
5 Yamada S, Takada K : Angiogenesis in pituitary adenomas. Microsc Res Tech 60 : 236-243, 2003   DOI   ScienceOn
6 Mohr G, Hardy J : Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 18 : 181-189, 1982   DOI   ScienceOn
7 Murad-Kejbou S, Eggenberger E : Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Ophthalmol 20 : 456-461, 2009   DOI   ScienceOn
8 Nawar RN, AbdelMannan D, Selman WR, Arafah BM : Pituitary tumor apoplexy: a review. J Intensive Care Med 23 : 75-90, 2008   DOI
9 Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, et al. : Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF) : A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci U S A 99 : 383-388, 2002   DOI   ScienceOn
10 Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ : Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJR Am J Roentgenol 153 : 153-160, 1989   DOI   ScienceOn
11 Pizarro CB, Oliveira MC, Pereira-Lima JF, Leães CG, Kramer CK, Schuch T, et al. : Evaluation of angiogenesis in 77 pituitary adenomas using endoglin as a marker. Neuropathology 29 : 40-44, 2009   DOI   ScienceOn
12 Semple PL, Jane JA, Lopes MB, Laws ER : Pituitary apoplexy : correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108 : 909-915, 2008   DOI   ScienceOn
13 Tammela T, Enholm B, Alitalo K, Paavonen K : The biology of vascular endothelial growth factors. Cardiovasc Res 65 : 550-563, 2005   DOI   ScienceOn
14 Turgut M, Ozsunar Y, Basak S, Guney E, Kir E, Meteoglu I : Pituitary apoplexy : an overview of 186 cases published during the last century. Acta Neurochir (Wien) 152 : 749-761, 2010   DOI   ScienceOn
15 Turner HE, Harris AL, Melmed S, Wass JA : Angiogenesis in endocrine tumors. Endocr Rev 24 : 600-632, 2003   DOI   ScienceOn
16 Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA : Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 85 : 1159-1162, 2000   DOI   ScienceOn
17 Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, et al. : Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 74 : 95-105, 2001   DOI   ScienceOn
18 Liotta LA, Steeg PS, Stetler-Stevenson WG : Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64 : 327-336, 1991   DOI   ScienceOn
19 Liu ZH, Chang CN, Pai PC, Wei KC, Jung SM, Chen NY, et al. : Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy. J Clin Neurosci 17 : 694-699, 2010   DOI   ScienceOn
20 Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L : Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10 : 229-235, 1999   DOI   ScienceOn
21 Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA : Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340 : 145-146, 1992   DOI   ScienceOn
22 Gould VE, Wagner BM : Angiogenesis: an expanding universe. Hum Pathol 33 : 1061-1063, 2002   DOI   ScienceOn
23 McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, et al. : Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87 : 4238-4244, 2002   DOI   ScienceOn
24 Garcia de la Torre N, Wass JA, Turner HE : Antiangiogenic effects of somatostatin analogues. Clin Endocrinol (Oxf) 57 : 425-441, 2002   DOI   ScienceOn
25 Gorczyca W, Hardy J : Microadenomas of the human pituitary and their vascularization. Neurosurgery 22 : 1-6, 1988   DOI
26 Hicklin DJ, Ellis LM : Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23 : 1011-1027, 2005   DOI
27 Ferrara N : Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25 : 581-611, 2004   DOI   ScienceOn
28 Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. : Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340 : 1120-1124, 1992   DOI   ScienceOn
29 Biousse V, Newman NJ, Oyesiku NM : Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71 : 542-545, 2001   DOI   ScienceOn
30 Bonneville JF, Cattin F, Gorczyca W, Hardy J : Pituitary microadenomas: early enhancement with dynamic CT--implications of arterial blood supply and potential importance. Radiology 187 : 857-861, 1993   DOI
31 Bergers G, Benjamin LE : Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 : 401-410, 2003   DOI   ScienceOn
32 Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH : Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma. J Clin Endocrinol Metab 52 : 95-97, 1981   DOI
33 Arita K, Kurisu K, Tominaga A, Sugiyama K, Eguchi K, Hama S, et al. : Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma. Hiroshima J Med Sci 53 : 23-27, 2004
34 Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR : Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 16 : 253-260, 2000